APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etiracetam

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Etiracetam Industry Growth and Trends Forecast to 2032

20 December 2025119 pages

Choose your research edition.

Industry ResearchEtiracetam Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Etiracetam Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Etiracetam Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etiracetam Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Etiracetam Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Etiracetam market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Etiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Etiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Etiracetam include UCB, APOTEX, Aurobindo, Hikma, Lupin, Pharmascience, Shenzhen Salubris Pharmaceuticals, Viatris and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Etiracetam market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Etiracetam market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Etiracetam market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Etiracetam.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Etiracetam market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Etiracetam Market by Company

UCB

APOTEX

Aurobindo

Hikma

Lupin

Pharmascience

Shenzhen Salubris Pharmaceuticals

Viatris

Changzhou Pharmaceutical Factory

Chengdu Leer Pharmaceutical

Zhejiang Huahai Pharmaceutical

China Resources Saike Pharmaceutical

Zhejiang Jingxin Pharmaceutical

Hainan Poly Pharm

Jiangsu Wangao Pharmaceutical

Etiracetam Segment by Type

Levetiracetam

Devetiracetam

Etiracetam Segment by Application

Hospital

Clinic

Etiracetam Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etiracetam market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etiracetam and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etiracetam.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Etiracetam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Etiracetam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Levetiracetam Table 2. Major Company of Devetiracetam Table 3. Global Etiracetam Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Etiracetam Sales by Type (2021-2026) & (kg) Table 5. Global Etiracetam Sales Market Share in Volume by Type (2021-2026) Table 6. Global Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 7. Global Etiracetam Sales Market Share in Value by Type (2021-2026) Table 8. Global Etiracetam Price by Type (2021-2026) & (US$/g) Table 9. Global Etiracetam Sales by Type (2027-2032) & (kg) Table 10. Global Etiracetam Sales Market Share in Volume by Type (2027-2032) Table 11. Global Etiracetam Sales by Type (2027-2032) & (US$ Million) Table 12. Global Etiracetam Sales Market Share in Value by Type (2027-2032) Table 13. Global Etiracetam Price by Type (2027-2032) & (US$/g) Table 14. North America Etiracetam Sales by Type (2021-2026) & (kg) Table 15. North America Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Etiracetam Sales by Type (2021-2026) & (kg) Table 17. Europe Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Etiracetam Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Etiracetam Sales by Type (2021-2026) & (kg) Table 21. Latin America Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Etiracetam Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Etiracetam Sales by Type (2021-2026) & (US$ Million) Table 24. Etiracetam Industry Trends Table 25. Etiracetam Industry Drivers Table 26. Etiracetam Industry Opportunities and Challenges Table 27. Etiracetam Industry Restraints Table 28. Global Etiracetam Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Etiracetam Revenue Market Share by Company (2021-2026) Table 30. Global Etiracetam Sales by Company (2021-2026) & (kg) Table 31. Global Etiracetam Sales Share by Company (2021-2026) Table 32. Global Etiracetam Market Price by Company (2021-2026) & (US$/g) Table 33. Global Etiracetam Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Etiracetam Major Company Production Sites and Headquarters Table 35. Global Etiracetam Company, Product Type & Application Table 36. Global Etiracetam Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Etiracetam by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Etiracetam Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Etiracetam Sales by Region (2021-2026) & (kg) Table 41. Global Etiracetam Sales Market Share in Volume by Region (2021-2026) Table 42. Global Etiracetam Sales by Region (2021-2026) & (US$ Million) Table 43. Global Etiracetam Sales Market Share in Value by Region (2021-2026) Table 44. Global Etiracetam Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Etiracetam Sales by Region (2027-2032) & (kg) Table 46. Global Etiracetam Sales Market Share in Volume by Region (2027-2032) Table 47. Global Etiracetam Sales by Region (2027-2032) & (US$ Million) Table 48. Global Etiracetam Sales Market Share in Value by Region (2027-2032) Table 49. Global Etiracetam Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Etiracetam Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Etiracetam Sales by Application (2021-2026) & (kg) Table 52. Global Etiracetam Sales Market Share in Volume by Application (2021-2026) Table 53. Global Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 54. Global Etiracetam Sales Market Share in Value by Application (2021-2026) Table 55. Global Etiracetam Price by Application (2021-2026) & (US$/g) Table 56. Global Etiracetam Sales by Application (2027-2032) & (kg) Table 57. Global Etiracetam Sales Market Share in Volume by Application (2027-2032) Table 58. Global Etiracetam Sales by Application (2027-2032) & (US$ Million) Table 59. Global Etiracetam Sales Market Share in Value by Application (2027-2032) Table 60. Global Etiracetam Price by Application (2027-2032) & (US$/g) Table 61. North America Etiracetam Sales by Application (2021-2026) & (kg) Table 62. North America Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Etiracetam Sales by Application (2021-2026) & (kg) Table 64. Europe Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Etiracetam Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Etiracetam Sales by Application (2021-2026) & (kg) Table 68. Latin America Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Etiracetam Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Etiracetam Sales by Application (2021-2026) & (US$ Million) Table 71. UCB Company Information Table 72. UCB Business Overview Table 73. UCB Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. UCB Etiracetam Product Portfolio Table 75. UCB Recent Development Table 76. APOTEX Company Information Table 77. APOTEX Business Overview Table 78. APOTEX Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. APOTEX Etiracetam Product Portfolio Table 80. APOTEX Recent Development Table 81. Aurobindo Company Information Table 82. Aurobindo Business Overview Table 83. Aurobindo Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Aurobindo Etiracetam Product Portfolio Table 85. Aurobindo Recent Development Table 86. Hikma Company Information Table 87. Hikma Business Overview Table 88. Hikma Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Hikma Etiracetam Product Portfolio Table 90. Hikma Recent Development Table 91. Lupin Company Information Table 92. Lupin Business Overview Table 93. Lupin Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Lupin Etiracetam Product Portfolio Table 95. Lupin Recent Development Table 96. Pharmascience Company Information Table 97. Pharmascience Business Overview Table 98. Pharmascience Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Pharmascience Etiracetam Product Portfolio Table 100. Pharmascience Recent Development Table 101. Shenzhen Salubris Pharmaceuticals Company Information Table 102. Shenzhen Salubris Pharmaceuticals Business Overview Table 103. Shenzhen Salubris Pharmaceuticals Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Shenzhen Salubris Pharmaceuticals Etiracetam Product Portfolio Table 105. Shenzhen Salubris Pharmaceuticals Recent Development Table 106. Viatris Company Information Table 107. Viatris Business Overview Table 108. Viatris Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Viatris Etiracetam Product Portfolio Table 110. Viatris Recent Development Table 111. Changzhou Pharmaceutical Factory Company Information Table 112. Changzhou Pharmaceutical Factory Business Overview Table 113. Changzhou Pharmaceutical Factory Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. Changzhou Pharmaceutical Factory Etiracetam Product Portfolio Table 115. Changzhou Pharmaceutical Factory Recent Development Table 116. Chengdu Leer Pharmaceutical Company Information Table 117. Chengdu Leer Pharmaceutical Business Overview Table 118. Chengdu Leer Pharmaceutical Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 119. Chengdu Leer Pharmaceutical Etiracetam Product Portfolio Table 120. Chengdu Leer Pharmaceutical Recent Development Table 121. Zhejiang Huahai Pharmaceutical Company Information Table 122. Zhejiang Huahai Pharmaceutical Business Overview Table 123. Zhejiang Huahai Pharmaceutical Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 124. Zhejiang Huahai Pharmaceutical Etiracetam Product Portfolio Table 125. Zhejiang Huahai Pharmaceutical Recent Development Table 126. China Resources Saike Pharmaceutical Company Information Table 127. China Resources Saike Pharmaceutical Business Overview Table 128. China Resources Saike Pharmaceutical Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 129. China Resources Saike Pharmaceutical Etiracetam Product Portfolio Table 130. China Resources Saike Pharmaceutical Recent Development Table 131. Zhejiang Jingxin Pharmaceutical Company Information Table 132. Zhejiang Jingxin Pharmaceutical Business Overview Table 133. Zhejiang Jingxin Pharmaceutical Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 134. Zhejiang Jingxin Pharmaceutical Etiracetam Product Portfolio Table 135. Zhejiang Jingxin Pharmaceutical Recent Development Table 136. Hainan Poly Pharm Company Information Table 137. Hainan Poly Pharm Business Overview Table 138. Hainan Poly Pharm Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 139. Hainan Poly Pharm Etiracetam Product Portfolio Table 140. Hainan Poly Pharm Recent Development Table 141. Jiangsu Wangao Pharmaceutical Company Information Table 142. Jiangsu Wangao Pharmaceutical Business Overview Table 143. Jiangsu Wangao Pharmaceutical Etiracetam Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 144. Jiangsu Wangao Pharmaceutical Etiracetam Product Portfolio Table 145. Jiangsu Wangao Pharmaceutical Recent Development Table 146. North America Etiracetam Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 147. North America Etiracetam Sales by Country (2021-2026) & (kg) Table 148. North America Etiracetam Sales Market Share by Country (2021-2026) Table 149. North America Etiracetam Sales Forecast by Country (2027-2032) & (kg) Table 150. North America Etiracetam Sales Market Share Forecast by Country (2027-2032) Table 151. North America Etiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Etiracetam Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Etiracetam Market Share by Country (2021-2026) Table 154. North America Etiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Etiracetam Market Share Forecast by Country (2027-2032) Table 156. Europe Etiracetam Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 157. Europe Etiracetam Sales by Country (2021-2026) & (kg) Table 158. Europe Etiracetam Sales Market Share by Country (2021-2026) Table 159. Europe Etiracetam Sales Forecast by Country (2027-2032) & (kg) Table 160. Europe Etiracetam Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Etiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Etiracetam Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Etiracetam Market Share by Country (2021-2026) Table 164. Europe Etiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Etiracetam Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Etiracetam Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Etiracetam Sales by Country (2021-2026) & (kg) Table 168. Asia-Pacific Etiracetam Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Etiracetam Sales Forecast by Country (2027-2032) & (kg) Table 170. Asia-Pacific Etiracetam Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Etiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Etiracetam Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Etiracetam Market Share by Country (2021-2026) Table 174. Asia-Pacific Etiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Etiracetam Market Share Forecast by Country (2027-2032) Table 176. Latin America Etiracetam Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 177. Latin America Etiracetam Sales by Country (2021-2026) & (kg) Table 178. Latin America Etiracetam Sales Market Share by Country (2021-2026) Table 179. Latin America Etiracetam Sales Forecast by Country (2027-2032) & (kg) Table 180. Latin America Etiracetam Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Etiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Etiracetam Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Etiracetam Market Share by Country (2021-2026) Table 184. Latin America Etiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Etiracetam Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Etiracetam Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Etiracetam Sales by Country (2021-2026) & (kg) Table 188. Middle East and Africa Etiracetam Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Etiracetam Sales Forecast by Country (2027-2032) & (kg) Table 190. Middle East and Africa Etiracetam Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Etiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Etiracetam Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Etiracetam Market Share by Country (2021-2026) Table 194. Middle East and Africa Etiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Etiracetam Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Etiracetam Distributors List Table 199. Etiracetam Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Etiracetam Image Figure 2. Global Etiracetam Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etiracetam Market Size (2021-2032) & (US$ Million) Figure 4. Global Etiracetam Sales (2021-2032) & (kg) Figure 5. Levetiracetam Image Figure 6. Global Levetiracetam Sales YoY Growth (2021-2032) & (kg) Figure 7. Devetiracetam Image Figure 8. Global Devetiracetam Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Etiracetam Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Etiracetam Market Share by Type 2025 VS 2032 Figure 11. North America Etiracetam Sales Market Share in Volume by Type in 2025 Figure 12. North America Etiracetam Sales Market Share in Value by Type in 2025 Figure 13. Europe Etiracetam Sales Market Share in Volume by Type in 2025 Figure 14. Europe Etiracetam Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Etiracetam Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Etiracetam Sales Market Share in Value by Type in 2025 Figure 17. Latin America Etiracetam Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Etiracetam Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Etiracetam Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Etiracetam Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Etiracetam Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (kg) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (kg) Figure 27. Global Etiracetam Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Etiracetam Market Share by Application 2025 VS 2032 Figure 29. North America Etiracetam Sales Market Share in Volume by Application in 2025 Figure 30. North America Etiracetam Sales Market Share in Value by Application in 2025 Figure 31. Europe Etiracetam Sales Market Share in Volume by Application in 2025 Figure 32. Europe Etiracetam Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Etiracetam Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Etiracetam Sales Market Share in Value by Application in 2025 Figure 35. Latin America Etiracetam Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Etiracetam Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Etiracetam Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Etiracetam Sales Market Share in Value by Application in 2025 Figure 39. North America Etiracetam Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 40. North America Etiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Etiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Etiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Etiracetam Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. Europe Etiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Etiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Etiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Etiracetam Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Asia-Pacific Etiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Etiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Etiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Etiracetam Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Latin America Etiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Etiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Etiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Etiracetam Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Middle East and Africa Etiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Etiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Etiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Etiracetam Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Etiracetam Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Levetiracetam
  • Devetiracetam
Applications
  • Hospital
  • Clinic
Companies covered
  • UCB
  • APOTEX
  • Aurobindo
  • Hikma
  • Lupin
  • Pharmascience
  • Shenzhen Salubris Pharmaceuticals
  • Viatris
  • Changzhou Pharmaceutical Factory
  • Chengdu Leer Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • China Resources Saike Pharmaceutical
  • Zhejiang Jingxin Pharmaceutical
  • Hainan Poly Pharm
  • Jiangsu Wangao Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etiracetam Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Etiracetam Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Etiracetam Market by Type
  6. 1.3.1 Levetiracetam
  7. 1.3.2 Devetiracetam
  8. 1.4 Global Etiracetam Market Size by Type
  9. 1.4.1 Global Etiracetam Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Etiracetam Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Etiracetam Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Etiracetam Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Etiracetam Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Etiracetam Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Etiracetam Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Etiracetam Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Etiracetam Industry Trends
  2. 2.2 Etiracetam Industry Drivers
  3. 2.3 Etiracetam Industry Opportunities and Challenges
  4. 2.4 Etiracetam Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Etiracetam Revenue (2021-2026)
  2. 3.2 Global Top Players by Etiracetam Sales (2021-2026)
  3. 3.3 Global Top Players by Etiracetam Price (2021-2026)
  4. 3.4 Global Etiracetam Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Etiracetam Major Company Production Sites & Headquarters
  6. 3.6 Global Etiracetam Company, Product Type & Application
  7. 3.7 Global Etiracetam Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Etiracetam Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Etiracetam Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Etiracetam Tier 1, Tier 2, and Tier 3
4 Etiracetam Regional Status and Outlook
  1. 4.1 Global Etiracetam Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Etiracetam Historic Market Size by Region
  3. 4.2.1 Global Etiracetam Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Etiracetam Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Etiracetam Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Etiracetam Forecasted Market Size by Region
  7. 4.3.1 Global Etiracetam Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Etiracetam Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Etiracetam Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Etiracetam by Application
  1. 5.1 Etiracetam Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Etiracetam Market Size by Application
  5. 5.2.1 Global Etiracetam Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Etiracetam Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Etiracetam Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Etiracetam Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Etiracetam Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Etiracetam Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Etiracetam Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Etiracetam Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 UCB
  2. 6.1.1 UCB Company Information
  3. 6.1.2 UCB Business Overview
  4. 6.1.3 UCB Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 UCB Etiracetam Product Portfolio
  6. 6.1.5 UCB Recent Developments
  7. 6.2 APOTEX
  8. 6.2.1 APOTEX Company Information
  9. 6.2.2 APOTEX Business Overview
  10. 6.2.3 APOTEX Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 APOTEX Etiracetam Product Portfolio
  12. 6.2.5 APOTEX Recent Developments
  13. 6.3 Aurobindo
  14. 6.3.1 Aurobindo Company Information
  15. 6.3.2 Aurobindo Business Overview
  16. 6.3.3 Aurobindo Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aurobindo Etiracetam Product Portfolio
  18. 6.3.5 Aurobindo Recent Developments
  19. 6.4 Hikma
  20. 6.4.1 Hikma Company Information
  21. 6.4.2 Hikma Business Overview
  22. 6.4.3 Hikma Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma Etiracetam Product Portfolio
  24. 6.4.5 Hikma Recent Developments
  25. 6.5 Lupin
  26. 6.5.1 Lupin Company Information
  27. 6.5.2 Lupin Business Overview
  28. 6.5.3 Lupin Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Etiracetam Product Portfolio
  30. 6.5.5 Lupin Recent Developments
  31. 6.6 Pharmascience
  32. 6.6.1 Pharmascience Company Information
  33. 6.6.2 Pharmascience Business Overview
  34. 6.6.3 Pharmascience Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pharmascience Etiracetam Product Portfolio
  36. 6.6.5 Pharmascience Recent Developments
  37. 6.7 Shenzhen Salubris Pharmaceuticals
  38. 6.7.1 Shenzhen Salubris Pharmaceuticals Company Information
  39. 6.7.2 Shenzhen Salubris Pharmaceuticals Business Overview
  40. 6.7.3 Shenzhen Salubris Pharmaceuticals Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shenzhen Salubris Pharmaceuticals Etiracetam Product Portfolio
  42. 6.7.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Etiracetam Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Changzhou Pharmaceutical Factory
  50. 6.9.1 Changzhou Pharmaceutical Factory Company Information
  51. 6.9.2 Changzhou Pharmaceutical Factory Business Overview
  52. 6.9.3 Changzhou Pharmaceutical Factory Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Changzhou Pharmaceutical Factory Etiracetam Product Portfolio
  54. 6.9.5 Changzhou Pharmaceutical Factory Recent Developments
  55. 6.10 Chengdu Leer Pharmaceutical
  56. 6.10.1 Chengdu Leer Pharmaceutical Company Information
  57. 6.10.2 Chengdu Leer Pharmaceutical Business Overview
  58. 6.10.3 Chengdu Leer Pharmaceutical Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Leer Pharmaceutical Etiracetam Product Portfolio
  60. 6.10.5 Chengdu Leer Pharmaceutical Recent Developments
  61. 6.11 Zhejiang Huahai Pharmaceutical
  62. 6.11.1 Zhejiang Huahai Pharmaceutical Company Information
  63. 6.11.2 Zhejiang Huahai Pharmaceutical Business Overview
  64. 6.11.3 Zhejiang Huahai Pharmaceutical Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhejiang Huahai Pharmaceutical Etiracetam Product Portfolio
  66. 6.11.5 Zhejiang Huahai Pharmaceutical Recent Developments
  67. 6.12 China Resources Saike Pharmaceutical
  68. 6.12.1 China Resources Saike Pharmaceutical Company Information
  69. 6.12.2 China Resources Saike Pharmaceutical Business Overview
  70. 6.12.3 China Resources Saike Pharmaceutical Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 China Resources Saike Pharmaceutical Etiracetam Product Portfolio
  72. 6.12.5 China Resources Saike Pharmaceutical Recent Developments
  73. 6.13 Zhejiang Jingxin Pharmaceutical
  74. 6.13.1 Zhejiang Jingxin Pharmaceutical Company Information
  75. 6.13.2 Zhejiang Jingxin Pharmaceutical Business Overview
  76. 6.13.3 Zhejiang Jingxin Pharmaceutical Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zhejiang Jingxin Pharmaceutical Etiracetam Product Portfolio
  78. 6.13.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  79. 6.14 Hainan Poly Pharm
  80. 6.14.1 Hainan Poly Pharm Company Information
  81. 6.14.2 Hainan Poly Pharm Business Overview
  82. 6.14.3 Hainan Poly Pharm Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hainan Poly Pharm Etiracetam Product Portfolio
  84. 6.14.5 Hainan Poly Pharm Recent Developments
  85. 6.15 Jiangsu Wangao Pharmaceutical
  86. 6.15.1 Jiangsu Wangao Pharmaceutical Company Information
  87. 6.15.2 Jiangsu Wangao Pharmaceutical Business Overview
  88. 6.15.3 Jiangsu Wangao Pharmaceutical Etiracetam Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Jiangsu Wangao Pharmaceutical Etiracetam Product Portfolio
  90. 6.15.5 Jiangsu Wangao Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Etiracetam Sales by Country
  2. 7.1.1 North America Etiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Etiracetam Sales by Country (2021-2026)
  4. 7.1.3 North America Etiracetam Sales Forecast by Country (2027-2032)
  5. 7.2 North America Etiracetam Market Size by Country
  6. 7.2.1 North America Etiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Etiracetam Market Size by Country (2021-2026)
  8. 7.2.3 North America Etiracetam Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Etiracetam Sales by Country
  2. 8.1.1 Europe Etiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Etiracetam Sales by Country (2021-2026)
  4. 8.1.3 Europe Etiracetam Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Etiracetam Market Size by Country
  6. 8.2.1 Europe Etiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Etiracetam Market Size by Country (2021-2026)
  8. 8.2.3 Europe Etiracetam Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Etiracetam Sales by Country
  2. 9.1.1 Asia-Pacific Etiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Etiracetam Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Etiracetam Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Etiracetam Market Size by Country
  6. 9.2.1 Asia-Pacific Etiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Etiracetam Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Etiracetam Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Etiracetam Sales by Country
  2. 10.1.1 South America Etiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Etiracetam Sales by Country (2021-2026)
  4. 10.1.3 South America Etiracetam Sales Forecast by Country (2027-2032)
  5. 10.2 South America Etiracetam Market Size by Country
  6. 10.2.1 South America Etiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Etiracetam Market Size by Country (2021-2026)
  8. 10.2.3 South America Etiracetam Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Etiracetam Sales by Country
  2. 11.1.1 Middle East and Africa Etiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Etiracetam Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Etiracetam Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Etiracetam Market Size by Country
  6. 11.2.1 Middle East and Africa Etiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Etiracetam Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Etiracetam Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Etiracetam Value Chain Analysis
  2. 12.1.1 Etiracetam Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Etiracetam Production Mode & Process
  7. 12.2 Etiracetam Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Etiracetam Distributors
  10. 12.2.3 Etiracetam Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst